Blog

(NASDAQ: RDFN) — Detroit, Cleveland, and Dayton, OH—all places where the median home-sale price is under $230,000—are the least expensive metro areas in the U.S. to buy a home, according to a new r

GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief

Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, today reported its financial results for the first quarter ended

Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, today announced the acquisition of Greenbids, a cutting-edge AI

Blackline Safety Corp. (TSX: BLN), a global leader in connected safety technology, announced today that its new EXO 8 area monitor — the world’s only direct-to-cloud portable area monitor capable

Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in AI-powered humanoid robotics, is pleased to announce a new collaboration with Tix4 Inc and

Kohl’s Corporation ("Kohl’s" or the "Company") (NYSE: KSS) announced today the commencement of a private offering (the “Offering”) of approximately $360 million aggregate principal amount of senior

Regis Corporation (NasdaqGM: RGS), a leader in the haircare industry, today announced financial results for the third fiscal quarter ended March 31, 2025.

Matthew Doctor, Regis Corporation's

On Holding AG (NYSE: ONON) (“On,” “On Holding AG,” the “Company,” “we,” “our,” “ours,” or “us”), has announced its financial results for the first quarter ended March 31, 2025.

Caspar Coppetti

FICO (NYSE: FICO):

Highlights:

• 
  Entercard will use AI-powered technology from FICO to better identify fraudulent account openings
  


• 
  Entercard will use FICO® Platform’s capabilities for model

Enterprises in Germany are increasing their investments in Microsoft AI tools and services despite uncertainties about how these technologies will pay off, according to a new research report

SES Space & Defense, a wholly-owned subsidiary of SES, joins the Defense Innovation Unit’s (DIU) Hybrid Space Architecture Network initiative. SES’s Hybrid Space Architecture II project will

Regulatory News:

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss

Regulatory News:

POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

T-Mobile (NASDAQ: TMUS):

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512348322/en/

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and first quarter 2025 financial results.

“This quarter we continued to advance

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the pricing of an underwritten offering consisting of 12,235,000 shares of its common stock and pre-funded

Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the third quarter of fiscal 2025 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, May 22, 2025.

On

Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2025.

First Quarter 2025 Highlights

• 
  Revenue

Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) has released its first quarter 2025 financial results by posting them to its website. Please visit the Cannae website at www.cannaehol

Power Integrations (NASDAQ: POWI) today announced financial results for the quarter ended March 31, 2025. Net revenues for the first quarter were $105.5 million, up slightly compared to the prior

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1x1 meetings and

Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, announced today that Mitch Haws

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the first quarter earnings call originally scheduled for 4:30p.m. Eastern on Monday, May 12 will be